Parts 1 and 2 of this 3-part series provided an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women and reviewed the role of proper skin care and topical therapies in this patient population. In Part 3, oral therapies including combination oral contraceptives, spironolactone, antibiotics, and isotretinoin are discussed along with important considerations that clinicians should keep in mind when selecting oral agents for management of AV in adult women.
Cutis. 2015 December;96(6):376-382.
James Q. Del Rosso, DO; Julie C. Harper, MD; Emmy M. Graber, MD, MBA; Diane Thiboutot, MD; Nanette B. Silverberg, MD; Lawrence F. Eichenfield, MD
All oral therapies that are used to treat AV in adult women warrant individual consideration of possible benefits versus risks. Careful attention to possible side effects, patient-related risk factors, and potential drug-drug interactions is important. End points of therapy are not well established, with the exception of oral isotretinoin therapy. Clinicians must use their judgment in each case along with obtaining feedback from patients regarding the selection of therapy after a discussion of the available options.
Click here to read more: http://www.cutis.com/specialty-focus/acne/article/status-report-from-the-american-acne-rosacea-society-on-medical-management-of-acne-in-adult-women-part-3-oral-therapies/97350264c3e4396169df800ab299c0ca.html
Medical Management of Acne in Adult Women
Part 1: Overview, Clinical Characteristics, and Laboratory Evaluation